Dr Reddy's shares rise as brokerages assess Q2 results
Shares rose in morning trade as brokerages highlighted a margin recovery and better-than-expected September-quarter profitability. Nomura kept its Buy rating but cut its target price; Citi raised its target, and Jefferies upgraded the stock.
Shares of Dr Reddy's Laboratories rose in morning trade on Monday as brokerages highlighted a sharp margin recovery and better-than-expected profitability in the September quarter.Nomura retained its 'Buy' rating but cut its target price, while Citi raised its target and Jefferies upgraded the stoc…